Search
Search
Editorially independent content, supported with advertising
02.17.22
New Retina Radio continues its biography of anti-VEGF. John D. Pitcher III, MD, picks up the story where we left off: in a world where pegaptanib was the only intravitreal injection approved for treating wet AMD. But a deep dive into the literature and a few calculations on the back of a napkin are about to change retina practice forever. Guests in this episode include Bob Avery, MD; Dave Brown, MD; Anne Fung, MD; Jeffrey Heier, MD; Andrew Moshfeghi, MD, MBA; Kirk Packo, MD; and Philip Rosenfeld, MD, PhD. This editorially independent podcast is supported with advertising.
02.24.22
Anti-VEGF, A Biography: Part 3John D. Pitcher III, MD; Bob Avery, MD; David Brown, MD; Jeffrey Heier, MD; Nancy Holekamp, MD; Kirk Packo, MD; Phillip Rosenfeld, MD, PhD; and Bob Vitti, MD
02.17.22
Anti-VEGF, A Biography: Part 2John D. Pitcher III, MD; Bob Avery, MD; Dave Brown, MD; Anne Fung, MD; Jeffrey Heier, MD; Andrew Moshfeghi, MD, MBA; Kirk Packo, MD; and Philip Rosenfeld, MD, PhD
01.27.22
Anti-VEGF, A Biography: Part 1John D. Pitcher III, MD; Tony Adamis, MD; Bob Avery, MD; Jeff Heier, MD; and Kirk Packo, MD
